Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
BiomedInnovations
AddedFeb 18, 2024
UpdatedJun 18, 2026
BiomedInnovations

BiomedInnovations

Angel

BiomedInnovations: Pioneering tech for long-term storage and interaction with human tissues/organs.

HQ
Denver, NC, US
Founded
2015
Overview
Compare
Fundraising
Employees

BiomedInnovations is dedicated to pioneering technology for the long-term storage and interaction with human tissues and organs outside the body. The company focuses on developing advanced medical devices aimed at improving the preservation and usability of large tissues and organs, targeting the healthcare and medical research markets.

BiomedInnovations has made significant strides in the medical technology field, contributing to advancements in organ preservation and transplantation. Their innovative solutions have the potential to revolutionize how medical professionals handle and store human tissues, enhancing patient outcomes and expanding research possibilities.

BiomedInnovations - Similar Companies

BMI OrganBank logo

BMI OrganBank

bmiorganbank.com

Paragonix Technologies logo

Paragonix Technologies

Blaire Biomedical logo

Blaire Biomedical

BioInspire Technologies logo

BioInspire Technologies

Infused Medical Technology logo

Infused Medical Technology

Biomimedica logo

Biomimedica

biomimedica.com

Intellimedix logo

Intellimedix

BioMedical Technologies Solutions logo

BioMedical Technologies Solutions

Tissue Regeneration logo

Tissue Regeneration

Mercury Biomed logo

Mercury Biomed

Niche Biomedical logo

Niche Biomedical

Advanced Biomedics logo

Advanced Biomedics

Velomedix logo

Velomedix

Aesthetics Biomedical logo

Aesthetics Biomedical

Innovative Trauma Care logo

Innovative Trauma Care

BiomedInnovations - Quick Facts

Who are BiomedInnovations' competitors?

Companies similar to BiomedInnovations include BMI OrganBank, Paragonix Technologies, Blaire Biomedical and BioInspire Technologies.

When was BiomedInnovations founded?

BiomedInnovations was founded in 2015.

Where is BiomedInnovations' headquarters located?

BiomedInnovations' headquarters is located in Denver, NC, US.

When was BiomedInnovations' last funding round?

BiomedInnovations' most recent funding round was for $250k (USD) in May 2020.

How much has BiomedInnovations raised to-date?

As of May 6, 2020, BiomedInnovations has raised a total of $250k (USD).

How many employees does BiomedInnovations have?

BiomedInnovations has 12 employees as of Feb 4, 2024.

BiomedInnovations - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified